Skip to main content
Top
Published in: American Journal of Clinical Dermatology 5/2004

01-10-2004 | Guest Commentary

Poly-L-Lactic Acid

A Viewpoint by Claudia Borelli and Hans Christian Korting

Authors: Claudia Borelli, Hans Christian Korting

Published in: American Journal of Clinical Dermatology | Issue 5/2004

Login to get access

Excerpt

Poly-L-lactic acid was recently approved as Sculptra™ in the US for the treatment of lipoatrophy in HIV-infected patients who had received previous antiretroviral therapy. Poly-L-lactic acid, a member of the alpha-hydroxy-acid group of compounds, is a synthetic biodegradable polymer used for the aesthetic correction of tissue loss in the face to create a younger and healthier look. Tissue loss of the face may be due to antiretroviral therapy and an ensuing lipoatrophy or due to personal predisposition. Poly-L-lactic acid increased the total cutaneous thickness in different studies in patients with HIV infection. The mechanism of tissue thickness increase is not yet really known; an induction of collagen production is under debate. …
Metadata
Title
Poly-L-Lactic Acid
A Viewpoint by Claudia Borelli and Hans Christian Korting
Authors
Claudia Borelli
Hans Christian Korting
Publication date
01-10-2004
Publisher
Springer International Publishing
Published in
American Journal of Clinical Dermatology / Issue 5/2004
Print ISSN: 1175-0561
Electronic ISSN: 1179-1888
DOI
https://doi.org/10.2165/00128071-200405050-00013

Other articles of this Issue 5/2004

American Journal of Clinical Dermatology 5/2004 Go to the issue

Therapy in Practice

Folliculitis

Review Article

Cosmetic Allergy

Adis Drug Profile

Poly-L-Lactic Acid

Original Research Article

Sympathomimetic Drug Allergy

Guest Commentary

Poly-L-Lactic Acid